Honey pivot absorbed $14.7m of working capital and added $13.2m debt

Inventories rose from $0.8m to $14.1m and gross borrowings from $0.2m to $13.2m to fund the stock. Headline revenue grew 469.6% to $2.4m, but $1.3m came from the new Honey segment. PBT and NPAT both worsened 120.1% to -$2.8m, while operating cash outflow widened to $4.6m from $1.6m. Total assets reached $46.2m versus $8.5m a year earlier.

• Inventory days reached 1,658.2 versus a historical mean of 689.5 - the company now holds years of honey stock on the balance sheet. Carrying value depends on sell-through assumptions with no operating history at this scale; any markdown would flow through equity.
• Permanent leverage against variable cash. Gross borrowings rose from $0.2m (essentially leases) to $13.2m, comprising $8.1m of bank loans and $5.1m of subordinated notes. Fixed debt service now sits against an operation generating -$1.8m EBITDA and a $4.6m operating cash outflow this half.
• Revenue growth is mix-driven, not organic. The new Honey segment supplied 51.8% of current revenue. Gross margin compressed from 64.2% to 35.8% (-2,833 bps) reflecting honey's lower-margin profile. The 469.6% headline does not represent the underlying wellness brand's trajectory; Sale of goods and Agency services both remained loss-making at the segment line.

The shape context is unusual: HY21 represented only 5.1% of FY21 full-year revenue and 6.4% of full-year NPAT, but FY21 itself is a 15-month transition period to a June balance date and therefore not directly comparable. Annualising HY22 at face value implies $4.8m of revenue, well below the $8.3m the company eventually reported across the 15-month full year. This release supports no clean run-rate inference because the honey strategy is mid-pivot and segment economics are not yet stable.

The 469.6% revenue growth is acquisition-driven rather than organic, and all three operating segments reported losses (Sale of goods -$0.8m, Agency services -$0.2m, Honey -$0.3m). Cash conversion of 253.4% is unprecedented against the supplied 4-period mean of 104.1%, but the ratio reads inverted here: both EBITDA (-$1.8m) and operating cash flow (-$4.6m) are negative, so a high ratio means cash burn materially exceeds the EBITDA loss because inventory and receivables absorbed $14.7m of working capital.

Pre-lease free cash flow was -$4.8m, below Annolyse's historical range of -$4.7m to -$1.1m, with only $2.3m of cash remaining. The combination of accelerating cash burn, a newly leveraged balance sheet, and unproven inventory turnover gives little visibility into earnings or cash for the next half. Receivable days improved to 144.6 from 221.9, but trade debtors still grew 271.2% to $1.9m as the receivables base expanded with revenue.

This briefing cannot assess management's specific commercial plans for honey sell-through, customer concentration, or whether the inventory is carried at recoverable value.